研究者業績
基本情報
研究キーワード
1研究分野
1論文
254-
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 27(3) 306-310 2024年9月We report a case in which excessive negative pressure may have been applied to the proximal side hole of a drainage cannula during venovenous extracorporeal membrane oxygenation (V-V ECMO), resulting in abnormal stenosis of the drainage cannula. V-V ECMO was introduced in a 71-year-old male patient who was transferred from another hospital for severe respiratory failure associated with varicella pneumonia and acute respiratory distress syndrome. Drainage was performed using a PCKC-V™ 24Fr (MERA, Japan) cannula via the right femoral vein with the tip of the cannula near the level of the diaphragm under fluoroscopy. Reinfusion was performed via the right internal jugular vein. Due to poor systemic oxygenation, the drainage cannula was withdrawn caudally and refixed to reduce the effect of recirculation. Two days later, drainage pressure dropped rapidly, and frequent ECMO flow interruption occurred due to poor drainage. An abdominal X-ray revealed abnormal stenosis of the proximal side hole site of the drainage cannula. We diagnosed that the drainage cannula was damaged, and it was replaced with another, namely a Medtronic Bio-Medicus™ 25 Fr (GETINGE, Sweden) cannula. However, the removed drainage cannula was not damaged, suggesting that the cannula was temporarily stenosed by momentary excessive negative pressure. In a multi-stage drainage cannula, the main drainage site is the proximal side hole, with little negative pressure applied at the apical foramen in a mock experimental ex vivo drainage test in a water tank. Hence, improvement of a multi-stage drainage cannula is recommended, such as adequate reinforcement of the side hole site with a wire.
-
Renal Replacement Therapy 10(1) 2024年8月27日Abstract Background Sepsis 3 definitions have shifted the focus from nonspecific inflammation to sepsis as an organ dysfunction caused by a dysregulated host response to infection. Neutrophils have become therapeutic targets because of their intimate but complex involvement in sepsis. We conducted ex vivo and animal experiments to apply a granulocyte and monocyte adsorption column, which is clinically used for inflammatory bowel disease, in sepsis. In this study, the biocompatibility was evaluated in sepsis-like hypercytokinemia. Methods Six female outbred pigs were anesthetized. Extracorporeal direct hemoperfusion (DHP) with an Adacolumn or a sham column was initiated after lipopolysaccharide (LPS) administration. The DHP was performed for 2 h at a blood flow rate (QB) of 30 or 60 mL/min. Blood samples were collected before and during the DHP (30, 60, 90, and 120 min). The percentage change in white blood cell count, platelet count, and cytokine concentration was compared between the Adacolumn and sham columns. Results The percentage change in white blood cells were 96 (95–98)% and 106 (101–108)% in the Adacolumn and sham groups, respectively, at QB = 60 mL/min (p < 0.01). The percentage change in platelets were 95 (90–96)% and 97 (93–99)% in the in the Adacolumn and sham groups, respectively, at QB = 60 mL/min (not significant; n.s.). At QB = 60 mL/min, the percentage change in tumor necrosis factor-α, interleukin (IL)-6, and IL-10 were 92 (81–106)%, 95 (93–102)%, and 98 (95–100)%, respectively, for the Adacolumn and 100 (95–102)%, 98 (87–104)%, and 97 (93–99)%, respectively, for the sham column. The percentage change in white blood cell counts, platelet counts, and all cytokines at QB = 30 and 60 mL/min showed similar trends. Conclusion The biocompatibility of the Adacolumn was evaluated using a porcine LPS-induced inflammation model. No decrease in platelet counts or significant cytokine production was observed, suggesting that the Adacolumn could be safely used in patients with sepsis with QB = 30–60 mL/min for 2 h. However, production of mediators other than cytokines remains unknown and requires further investigation.
-
Acute medicine & surgery 11(1) e929 2024年Post-intensive care syndrome comprises physical, cognitive, and mental impairments in patients treated in an intensive care unit (ICU). It occurs either during the ICU stay or following ICU discharge and is related to the patients' long-term prognosis. The same concept also applies to pediatric patients, and it can greatly affect the mental status of family members. In the 10 years since post-intensive care syndrome was first proposed, research has greatly expanded. Here, we summarize the recent evidence on post-intensive care syndrome regarding its pathophysiology, epidemiology, assessment, risk factors, prevention, and treatments. We highlight new topics, future directions, and strategies to overcome post-intensive care syndrome among people treated in an ICU. Clinical and basic research are still needed to elucidate the mechanistic insights and to discover therapeutic targets and new interventions for post-intensive care syndrome.
-
Journal of clinical biochemistry and nutrition 74(1) 74-81 2024年1月The impact of nutrition therapy in the acute phase on post-intensive care syndrome (PICS) remains unclear. We conducted a multicenter prospective study on adult patients with COVID-19 who required mechanical ventilation for more than three days. The questionnaire was mailed after discharge. Physical PICS, defined as less than 90 points on the Barthel index (BI), was assigned as the primary outcome. We examined the types of nutrition therapy in the first week that affected PICS components. 269 eligible patients were evaluated 10 months after discharge. Supplemental parenteral nutrition (SPN) >400 kcal/day correlated with a lower occurrence of physical PICS (10% vs 21.92%, p = 0.042), whereas the amounts of energy and protein provided, early enteral nutrition, and a gradual increase in nutrition delivery did not, and none correlated with cognitive or mental PICS. A multivariable regression analysis revealed that SPN had an independent impact on physical PICS (odds ratio 0.33, 95% CI 0.12-0.92, p = 0.034), even after adjustments for age, sex, body mass index and severity. Protein provision ≥1.2 g/kg/day was associated with a lower occurrence of physical PICS (odds ratio 0.42, 95% CI 0.16-1.08, p = 0.071). In conclusion, SPN in the acute phase had a positive impact on physical PICS for ventilated patients with COVID-19.
-
日本呼吸ケア・リハビリテーション学会誌 32(1) 84-90 2023年12月 査読有り【目的】重症患者における入院関連能力障害(HAD)と退院後の介護予防の必要性との関連を調査することである.【対象と方法】2021年9月から2022年3月にICUにて48時間以上の人工呼吸管理を施行した20歳以上の患者を対象とする前向き観察研究である.HADの有無の2群で背景因子,退院3ヵ月後の転帰と生活状況等について比較した.生活状況の調査は基本チェックリストを用いて郵送にて行った.また,多重ロジスティック回帰分析を用いてHAD発生に関与する因子を抽出した.【結果】65例が解析対象者となった.HADは21例に発生した.HAD群で退院3ヵ月後の運動機能低下とフレイルの割合が有意に高かった.また,HAD発生の関連因子としてICU退室時の握力とFunctional Status Score for the ICU合計が抽出された.【結論】HAD群で退院3ヵ月後にフレイルを呈した症例が多かった.(著者抄録)
MISC
164-
CRITICAL CARE MEDICINE 43(12) 2015年12月
-
救急医学 = The Japanese journal of acute medicine 39(12) 1661-1668 2015年11月
-
人工臓器(日本人工臓器学会) 44(2) S.43 2015年10月30日
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 39(8) 443-448 2015年8月
-
ICUとCCU 39(8) 449-456 2015年8月日本版重症敗血症診療ガイドライン2016(日本版GL 2016)作成において、「アカデミックガイドライン(GL)推進班」と呼ばれる、どの領域にも属さないグループが組織された。全領域を俯瞰的に眺めながら、各領域のクリニカルクエスチョン(CQ)作成・システマティックレビュー(SR)工程に関し、サポート・監査を行うことが本班の主な任務である。CQ案策定の過程において、1)SSCG 2012と日本版GL 2012のCQ・推奨度の比較、2)新規のランダム化比較試験、および3)日本版GL 2016のCQ案を含めたデータベースを構築した。CQ作成はGLの骨子であり最重要事項である。本データベースを参考に査読を行い、CQ案の改訂を各ワーキンググループで行っていただいた。作成されたCQ案は、委員会を経てさらに改定され、パブリックコメント募集まで至った。今後は各領域におけるSRのサポートをアカデミックGL推進班の活動として継続していく予定である。(著者抄録)
-
The 34th Annual Conference of the KSCCM 2015年8月 査読有り
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 38(8) 523-530 2014年8月
-
Emergency care = エマージェンシー・ケア : 日本救急看護学会準機関誌 27(6) 594-597 2014年6月
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 38(2) 107-114 2014年2月
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 38(2) 123-129 2014年2月
-
救急医学 = The Japanese journal of acute medicine 38(2) 218-221 2014年2月
-
日本アフェレシス学会雑誌 33 97-97 2014年
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 37(12) 897-903 2013年12月
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 37(12) 929-937 2013年12月
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 37(8) 603-611 2013年8月
-
ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学 37(4) 263-271 2013年4月
-
Crit Care 17(Suppl 1) 2013年 査読有り
-
Surviving ICU シリーズARDSの治療戦略「知りたい」に答える、現場の知恵とエビデンス 207-209 2013年
-
34th European Society for Clinical Nutrition and Metabolism 2012年 査読有り
-
Crit Care 16(Suppl 1) 379-379 2012年 査読有り
書籍等出版物
46講演・口頭発表等
222共同研究・競争的資金等の研究課題
4-
日本学術振興会 科学研究費助成事業 2022年4月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 2020年4月 - 2023年3月
-
日本学術振興会 科学研究費助成事業 2020年4月 - 2023年3月
-
日本学術振興会 科学研究費助成事業 2017年4月 - 2023年3月